|
Ovarian Cancer Research Fund (OCRF) was founded in December, 1994, as the Ann Schreiber Ovarian Cancer Research Fund by Sol Schreiber in memory of his wife, Ann, who died of ovarian cancer. The organization later became the Ovarian Cancer Research Fund. In 1997, Liz Tilberis, editor-in-chief of Harpers Bazaar and also battling ovarian cancer,〔("Ovarian Cancer: Fighting for a Cure," ) Harper's Bazaar, June 3, 2009〕 became the organization’s first president. Liz, with help from Donna Karan, started OCRF’s signature fundraiser, Super Saturday, hosting the first one in 1998 in the Hamptons in New York. The first Super Saturday raised $200,000, and today raises over $3.5 million annually.〔("A Super Size Tag Sale is Turning 15," ) The New York Times, Fashion & Style, July 26, 2012, p. E6〕 OCRF is now the oldest and largest charity in the U.S. funding ovarian cancer research.〔(Charity Navigator )〕 OCRF has awarded over $50 million in research through grants to scientists at 63 medical centers in 29 states and Washington, D.C. OCRF launched a patient program in 2012, called Woman to Woman, for women undergoing treatment for any type of gynecologic cancer. OCRF is governed by a Board of Directors. The majority of ovarian cancer research funding in the United States comes from two government sources—the National Cancer Institute and United States Department of Defense. OCRF is the largest non-governmental funding source of ovarian cancer research,.〔(Ovarian Cancer Research Funding in the United States: Ovarian Cancer Research Fund )〕 OCRF research grants are approved by a committee of gynecologic oncologists and scientists treating and/or studying ovarian cancer.〔(Research Media Ltd. ), August 28, 2013〕 == Research == Through grantmaking programs, OCRF funds scientific research at cancer centers and academic research centers in the U.S. The first grants were awarded in 1998. OCRF offers three grants:〔(Research and Grants: Ovarian Cancer Research Fund )〕 *Program Project Development Grant: OCRF’s largest grant ($900,000 over three years) is for senior investigators with established research careers, and provides funding for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions. ($300,000 per year for three years) *Liz Tilberis Early Career Award: This award is for junior faculty, and supports a time commitment to research and academic endeavors in ovarian cancer. ($150,000 per year for three years). *Ann Schreiber Mentored Investigator Award: This award was created in 2003, and funds clinical fellows or post-doctoral fellows working under the supervision of a mentor who is considered a leader in the field of ovarian cancer research. ($75,000 over one or two years) OCRF selects research projects through a peer-review process, conducted once each year by a panel of advisors called the Scientific Advisory Committee (SAC), which is chaired by Jeff Boyd, Ph.D., of Fox Chase Cancer Center. Less than 10% of applicants are awarded grants. Institutions that have received the most grants include University of Texas MD Anderson Cancer Center, University of Pennsylvania, Fox Chase Cancer Center, Duke University, and Brigham and Women’s Hospital. OCRF presents an educational webinar series featuring speakers on topics in ovarian cancer research and addresses clinical trial enrollment with an ovarian cancer clinical trial finder on its website.〔(Find a Clinical Trial: Ovarian Cancer Research Fund )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Ovarian Cancer Research Fund」の詳細全文を読む スポンサード リンク
|